A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy
Translational and Clinical Pharmacology · 2021 · 29 (1) · 6
DOI: 10.12793/tcp.2021.29.e1 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Translational and Clinical Pharmacology, 2021. Verfasst von JuYeun Jeon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Focal epilepsy is the most common type of epilepsy in Korea, and anti-epileptic drugs (AEDs) are the main treatment option for patients. This study aimed to compare the efficacy and safety of AEDs for focal epilepsy through a meta-analysis. The AEDs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy were included for analysis. Relevant articles were searched for randomized clinical trials of AEDs and treatment outcomes were analyzed on the basis of the 50% responder rate, seizure-free rate, treatment withdrawal rate, and emergence rates of adverse events (AEs). The odds ratios (ORs) and their 95% confidence intervals (CI) of study outcome were calculated using combined data from multiple studies. A total of 47 studies were included in the meta-analysis. The seizure-free rate, treatment withdrawal rate, and AE rate were not significantly different among the AEDs recommended for monotherapy. Among the AEDs recommended for adjunctive treatment, topiramate and oxcarbazepine yielded the highest OR in comparison with placebo for each efficacy parameter: the 50% responder rate for topiramate = 6.42 (3.76-11.6) and the seizure-free rate for oxcarbazepine = 32.7 (6.05-899). The third-generation AEDs (brivaracetam and perampanel) yielded relatively better safety outcomes than other AEDs. In general, the 50% responder rate and treatment withdrawal rate tended to increase as the dose of the AEDs increased. The results from the current meta-analysis of the efficacy and safety data of various AEDs may provide insight into optimal pharmacotherapy for the treatment of focal epilepsy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul 03080, Korea.
ORCID-Profile: JuYeun Jeon, Jaeseong Oh, Kyung-Sang Yu
Zitieren
APA
Jeon, J., Oh, J., & Yu, K. S. (2021). A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy. Translational and Clinical Pharmacology, 29(1), 6. https://doi.org/10.12793/tcp.2021.29.e1
Vancouver
Jeon J, Oh J, Yu KS. A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy. Translational and Clinical Pharmacology. 2021;29(1):6. doi:10.12793/tcp.2021.29.e1
BibTeX
@article{Jeon2021,
author = {Jeon, JuYeun and Oh, Jaeseong and Yu, Kyung-Sang},
title = {A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy},
journal = {Translational and Clinical Pharmacology},
year = {2021},
volume = {29},
number = {1},
pages = {6},
doi = {10.12793/tcp.2021.29.e1}
}
EUVIMED